About TRIP
Tracking Research in Psychedelics
Our Mission
TRIP is a public data infrastructure project that aggregates, enriches, and organizes scholarly literature on psychedelic compounds. Our goal is to make psychedelic research more accessible to scientists, clinicians, policymakers, and the public.
What We Track
We currently track 53,486 research papers across 26 psychedelic compounds. Click any tile for an AI-generated overview cited by the top papers in our database.
What You Can Do
Build a personalized literature review. Save papers, organize them into a guide, and export a structured report with AI-generated summaries.
Browse active and completed psychedelic clinical trials sourced from ClinicalTrials.gov, filterable by compound, phase, and status.
Search the psychedelic patent landscape — formulations, delivery methods, therapeutic applications, and synthesis routes filed worldwide.
Ask questions and get answers grounded in the TRIP database. TRIPPY is an AI research assistant that cites real papers from our index.
Data Sources
TRIP indexes paper metadata — titles, abstracts, authors, and DOIs — sourced from open-access platforms including PubMed / NCBI and OpenAlex. Individual papers are the intellectual property of their respective authors and publishers. TRIP does not host or reproduce full-text articles — all DOI links direct to the original publication.
Disclaimer
TRIP is a research aggregation tool for scientific literature. It is not a medical resource and does not provide medical advice, clinical recommendations, or guidance on the use of any substance.
The findings described in papers indexed here represent the views of their authors, not of TRIP. Do not make personal health or clinical decisions based on this tool. Always consult a licensed healthcare provider.
Contact
Have questions, suggestions, or want to collaborate? We'd love to hear from you.
tripforscience@gmail.comBuilt by Brock Pluimer, PhD